NASDAQ:NLOK - NortonLifeLock Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $26.57
Forecasted Upside: 0.38 %
Number of Analysts: 8
Breakdown:
0 Sell Ratings
3 Hold Ratings
5 Buy Ratings
0 Strong Buy Ratings

^$26.47 As of 05/18/2021 12:57 PM ET

▲ +0.36 (1.38%)

1 month | 3 months | 12 months

Get New NortonLifeLock Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for NLOK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NLOK

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$26.57

▲ +0.38% Upside Potential

This price target is based on 8 analysts offering 12 month price targets for NortonLifeLock in the last 3 months. The average price target is $26.57, with a high forecast of $30.00 and a low forecast of $24.00. The average price target represents a 0.38% upside from the last price of $26.47.

One pot stock could skyrocket with looming interstate sales

From All Marijuana Stocks

A new bill in Congress would decriminalize marijuana nationally by removing cannabis from the federal government’s list of controlled substances. The law would also allow one established Seattle cannabis company to market across state lines for the first time – potentially setting off a bidding war that could blast this stock into the stratosphere!

Buy

The current consensus among 8 polled investment analysts is to buy stock in NortonLifeLock.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
3 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

11/24/2019

0 strong buy ratings
5 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

2/22/2020

0 strong buy ratings
6 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

5/22/2020

0 strong buy ratings
6 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

8/20/2020

0 strong buy ratings
7 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

11/18/2020

0 strong buy ratings
5 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

2/16/2021

0 strong buy ratings
6 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

4/17/2021

0 strong buy ratings
5 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

5/17/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
5/18/2021	Bank of America	Upgrade	Underperform ➝ Buy	$30.00	Low	i
5/18/2021	Morgan Stanley	Boost Price Target	Overweight	$26.00 ➝ $28.00	Low	i
5/12/2021	Morgan Stanley	Boost Price Target	Overweight	$26.00 ➝ $28.00	High	i
5/12/2021	Bank of America	Upgrade	Underperform ➝ Buy	$30.00	High	i
4/19/2021	Bank of America	Initiated Coverage	Underperform	$19.00	N/A	i
4/13/2021	Bank of America	Initiated Coverage	Underperform	$19.00	High	i
2/5/2021	Credit Suisse Group	Boost Price Target	Neutral	$22.00 ➝ $24.00	Medium	i
2/5/2021	Morgan Stanley	Boost Price Target	Overweight	$25.50 ➝ $26.00	High	i
11/11/2020	Morgan Stanley	Lower Price Target	Overweight	$27.00 ➝ $25.50	High	i
9/1/2020	Morgan Stanley	Boost Price Target	Overweight	$25.00 ➝ $27.00	Low	i Rating by Keith Weiss at Morgan Stanley
8/28/2020	Robert W. Baird	Reiterated Rating	Buy		Low	i Rating by Jonathan Ruykhaver at Robert W. Baird
8/21/2020	Argus	Upgrade	Hold ➝ Buy	$27.00	Low	i
8/10/2020	Citigroup	Boost Price Target	Neutral	$21.00 ➝ $25.00	Low	i
8/7/2020	Oppenheimer	Reiterated Rating	Hold		Low	i
8/7/2020	Mizuho	Boost Price Target	Buy	$23.00 ➝ $27.00	Medium	i
8/7/2020	Robert W. Baird	Reiterated Rating	Buy		High	i Rating by Jonathan Ruykhaver at Robert W. Baird
6/8/2020	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$24.00 ➝ $25.00	High	i Rating by Jonathan Ruykhaver at Robert W. Baird
5/15/2020	Robert W. Baird	Boost Price Target	Neutral	$20.00 ➝ $24.00	High	i
5/15/2020	Credit Suisse Group	Boost Price Target	Neutral	$17.00 ➝ $19.00	Medium	i Rating by Brad Zelnick at Credit Suisse Group AG
5/15/2020	Citigroup	Boost Price Target	Neutral	$19.00 ➝ $21.00	Medium	i
5/15/2020	UBS Group	Boost Price Target	Buy	$23.00 ➝ $26.00	Medium	i
5/15/2020	Stifel Nicolaus	Boost Price Target	Hold	$19.00 ➝ $21.00	High	i
5/15/2020	Morgan Stanley	Boost Price Target	Overweight	$23.00 ➝ $25.00	High	i Rating by Keith Weiss at Morgan Stanley
5/15/2020	Oppenheimer	Reiterated Rating	Hold		High	i
5/15/2020	Mizuho	Boost Price Target	Positive ➝ Buy	$21.00 ➝ $23.00	High	i Rating by Gregg Moskowitz at Mizuho
3/25/2020	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$23.00	Low	i
2/7/2020	Wells Fargo & Company	Lower Price Target	Equal Weight	$25.00 ➝ $20.00	High	i
2/4/2020	Royal Bank of Canada	Lower Price Target	Sector Perform ➝ Positive	$17.00	High	i
2/4/2020	Robert W. Baird	Lower Price Target	Neutral	$26.00 ➝ $17.00	Medium	i
2/4/2020	Mizuho	Boost Price Target	Buy	$21.00	Low	i Rating by Gregg Moskowitz at Mizuho
2/4/2020	Credit Suisse Group	Lower Price Target	Neutral	$26.00 ➝ $14.00	Low	i Rating by Brad Zelnick at Credit Suisse Group AG
2/3/2020	Robert W. Baird	Reiterated Rating	Hold		Low	i
1/13/2020	Robert W. Baird	Reiterated Rating	Hold	$26.00	Low	i
1/6/2020	Barclays	Upgrade	Equal Weight ➝ Overweight	$32.00	N/A	i
12/17/2019	UBS Group	Boost Price Target	Buy	$27.00 ➝ $29.00	Low	i
12/10/2019	Mizuho	Reiterated Rating	Buy	$28.00	Low	i Rating by Gregg Moskowitz at Mizuho
11/27/2019	Credit Suisse Group	Initiated Coverage	Neutral	$26.00	Low	i
11/8/2019	Royal Bank of Canada	Initiated Coverage	Sector Perform		N/A	i
11/6/2019	Barclays	Initiated Coverage	Equal Weight		N/A	i
11/6/2019	Mizuho	Initiated Coverage	Buy		N/A	i

(Data available from 5/18/2016 forward)

NortonLifeLock Inc. provides cyber safety solutions for consumers worldwide. The company offers Norton security solutions as a subscription service providing protection for PCs, Macs, and mobile devices against malware, viruses, adware, ransomware, and other online threats on various platforms; and LifeLock identity theft protection solution that offers monitoring, alerts, and restoration services to its customers. It also provides Norton Secure VPN and SurfEasy VPN for online privacy, as well as Norton family, a solution for home and family, which offers protection and security, parental control, and GPS location monitoring services. NortonLifeLock Inc. markets and sells its products and related services through retailers, telecom service providers, hardware original equipment manufacturers, and employee benefit providers, as well as e-commerce platform. The company was formerly known as Symantec Corporation and changed its name to NortonLifeLock Inc. in November 2019. NortonLifeLock Inc. was founded in 1982 and is headquartered in Tempe, Arizona.

Today's Range

Now: $26.47

$26.07

$26.58

50 Day Range

MA: $22.12

$20.82

$26.09

52 Week Range

Now: $26.47

$17.98

$26.53

Volume

182,752 shs

Average Volume

5,678,086 shs

Market Capitalization

$15.40 billion

P/E Ratio

5.23

Dividend Yield

1.92%

Beta

0.79

Frequently Asked Questions

What sell-side analysts currently cover shares of NortonLifeLock?

The following equities research analysts have issued reports on NortonLifeLock in the last twelve months: Argus, Bank of America Co., Citigroup Inc., Credit Suisse Group AG, Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Robert W. Baird, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for NLOK.

What is the current price target for NortonLifeLock?

7 Wall Street analysts have set twelve-month price targets for NortonLifeLock in the last year. Their average twelve-month price target is $26.57, suggesting a possible upside of 1.8%. Bank of America Co. has the highest price target set, predicting NLOK will reach $30.00 in the next twelve months. Credit Suisse Group AG has the lowest price target set, forecasting a price of $24.00 for NortonLifeLock in the next year.
View the latest price targets for NLOK.

What is the current consensus analyst rating for NortonLifeLock?

NortonLifeLock currently has 3 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NLOK will outperform the market and that investors should add to their positions of NortonLifeLock.
View the latest ratings for NLOK.

What other companies compete with NortonLifeLock?

Other companies that are similar to NortonLifeLock include Autodesk, Dassault Systèmes, Twilio, CrowdStrike, Electronic Arts, Veeva Systems, Palantir Technologies, DocuSign, Synopsys, Cadence Design Systems, Okta, Atlassian, ANSYS, Datadog and Unity Software.

How do I contact NortonLifeLock's investor relations team?

NortonLifeLock's physical mailing address is 60 E RIO SALADO PARKWAY SUITE 1000, TEMPE AZ, 85281. The company's listed phone number is 650-527-8000. The official website for NortonLifeLock is www.nortonlifelock.com.

One pot stock could skyrocket with looming interstate sales

From All Marijuana Stocks